- Presentations
- 2
- Markets
- 2
Sivextro is a brand of Tedizolid marketed by Merck Sharp & Dohme, with 2 presentations listed and registered in European Union, United States. Each presentation below has its own page with packs, documents and availability for export supply from India.
- Active ingredient (INN)
- Tedizolid
- Brand owner
- Merck Sharp & Dohme
- Registered in
- European Union, United States
- Strengths and forms
- 200 mg/4 mL powder for injection, 200 mg tablet
All presentations
| Medicine | Manufacturer | Register | Availability |
|---|---|---|---|
| Sivextro 200 mg/4 mL powder for injectionIntravenous | Merck Sharp & Dohme | US FDA | Available on request |
| Sivextro 200 mg tabletOral | Merck Sharp & Dohme | US FDA | Available on request |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Sivextro
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.